Founderland Logofounderland
the ★ top ★ 100 ★ marketers ★
SavedSearch
FoundersFounders
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Product Launches
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Investment News
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Research & Innovation
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
FoundersFounders
2640

Dr. Philip Weissbrod

Logo
Dr. Philip Weissbrod
CEO & Co-Founder of
Channel Robotics (2023)
About

Dr. Philip Weissbrod is Co-Founder and CEO of Channel Robotics, a surgical robotics company pioneering AI-enhanced, handheld robotic systems that bring precision endoscopy to a far wider patient population without the cost or footprint of traditional tower-based platforms.

Before founding

Dr. Weissbrod earned his BA from Washington University in St. Louis and his MD from Stony Brook University, completing his residency at the New York Eye and Ear Infirmary and a fellowship in laryngology at the University of Washington.

Founder Insights

A Professor and inaugural Chair of Otolaryngology at UC San Diego School of Medicine, Dr. Weissbrod holds multiple patents in AI-powered robotic systems, steerable catheters, and endoscopic devices, and was named Faculty Innovator of the Year in 2024 by the Institute for the Global Entrepreneur.

Experience

He founded and directs the Center for Airway, Voice and Swallowing at UC San Diego Health, and co-led years of NIH-funded research with co-founder Professor Michael Yip before commercializing Channel Robotics.

Scale & Impact

Channel Robotics has raised $1.61M in Seed funding, completed Phase 1 industrial design with bench and cadaveric testing, and is actively pursuing FDA 510(k) clearance for its first device.

2640

Dr. Philip Weissbrod

Channel Robotics
Co-Founder
Logo
Dr. Philip Weissbrod

Company(s)

Channel Robotics

Industry

Healthtech & Biotech

Year Founded

2023

Stage/Funding

Seed • $1.61M

Company Location

us

Connect

About

Dr. Philip Weissbrod is Co-Founder and CEO of Channel Robotics, a surgical robotics company pioneering AI-enhanced, handheld robotic systems that bring precision endoscopy to a far wider patient population without the cost or footprint of traditional tower-based platforms.

Before founding

Dr. Weissbrod earned his BA from Washington University in St. Louis and his MD from Stony Brook University, completing his residency at the New York Eye and Ear Infirmary and a fellowship in laryngology at the University of Washington.

Founder Insights

A Professor and inaugural Chair of Otolaryngology at UC San Diego School of Medicine, Dr. Weissbrod holds multiple patents in AI-powered robotic systems, steerable catheters, and endoscopic devices, and was named Faculty Innovator of the Year in 2024 by the Institute for the Global Entrepreneur.

Experience

He founded and directs the Center for Airway, Voice and Swallowing at UC San Diego Health, and co-led years of NIH-funded research with co-founder Professor Michael Yip before commercializing Channel Robotics.

Scale & Impact

Channel Robotics has raised $1.61M in Seed funding, completed Phase 1 industrial design with bench and cadaveric testing, and is actively pursuing FDA 510(k) clearance for its first device.

About

Dreamwell AIContact UsOur Story

Articles

Product LaunchesInvestment NewsResearch & Innovation

founderland

We Use Cookies

We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.